Cytomedix's AutoloGel chronic wound care system re-launched under Aurix brand

Oct 15 2014

Initiates Broader Corporate Re-Branding Initiatives

Cytomedix (OTCQX: CMXI), a pioneer in biodynamic therapies, today announced that it has re-launched its AutoloGel chronic wound care system under the Aurix^TM brand. The formal launch of Aurix is an integral part of the Company’s full scale marketing plan for the commercialization of Aurix in the multi-billion dollar U.S. chronic wound care market.

The Aurix System™ website (www.aurixsystem.com) launched today in preparation for management’s participation at The Symposium on Advanced Wound Care (SAWC) Fall Meeting, being held October 16-18, 2014 in Las Vegas, Nevada.

“Since April of this year we have been laser-focused on refining the marketing strategy and commercial model, including recruiting the sales team to successfully launch Aurix into the U.S. marketplace,” said Dean Tozer, Chief Commercial Officer of Cytomedix. “With a direct sales team of nearly twenty representatives now in place in the hospital outpatient as well as Veterans Affairs settings, we are poised to begin full scale product promotion. The broad Aurix label provides clearance from the FDA for the product to treat multiple types of chronic wounds, which total more than 6 million wounds every year in the United States.”

The Aurix System itself has not been changed in any way and will continue to offer physicians and patients a proven solution for hard to treat skin ulcers and wounds that can have significant impact on a patient’s quality of life. Aurix is a biodynamic hematogel that harnesses a patient’s innate healing mechanisms in order to jumpstart the healing process from deep within the wound bed.

Chief Executive Officer, Marin Rosendale added:

Over the last 10 months, Cytomedix has transformed its organizational focus, with an emphasis on developing the commercial capabilities necessary to support this re-launch. We have out-licensed non-core assets, closed our R&D facility and raised the necessary capital to build and equip a world-class commercial team. The launch of Aurix signals the first major milestone in this new commercial strategy.